Image - Navigated Resection of Lung Nodules

Study summary

This is an open label study lung nodules that are either cancer or non-cancer and who are eligible for surgical resection. Patients will undergo their surgery with the help of the Lung Resection Marker Locator Kit which will assist the surgeon in both the location and resection of the lung nodule under real-time guidance.

Ask AI to explain this study

Start here

Key things to know

Main goalDevice Feasibility

This describes the study’s primary purpose.

What is being studiedlung resection with Lung Resection Marker Locator Kit

The study team can explain what participation involves.

Who it may be forLung Diseases

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jul 29, 2025 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Phase 1 / Phase 2

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Navigation Sciences, Inc.

Study sponsor

Study overview

What this study is about

Purpose: Device Feasibility
Study type: Interventional
Phase: Phase 1 / Phase 2
Sponsor: Navigation Sciences, Inc.
Interventions being studied: Device: lung resection with Lung Resection Marker Locator Kit

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Surgery→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

1. Males or females aged 21 years or older as it is extremely rare for younger people to be at risk for lung cancers. 2. Be deemed candidates for the lung resection surgery, which will be determined by their treating Thoracic Surgeon (also a physician investigator) 3. Have lesions that are nodules/GGO or other abnormal opacity that can be accurately measured in at least one dimension using conventional techniques 4. Seen at BWH Thoracic Surgery outpatient clinics or as inpatient (Note: Subjects will be formally consented to the study at BWH only)

Reasons someone may not be able to joinExclusion criteria

1. Female subjects pregnant or breastfeeding 2. Subjects with a pacemaker or equivalent devices (AICD) due to the use of electromagnetic tracking generator. 3. Patients who are not scheduled for lung surgery \-

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Brigham and Women's HospitalBoston, Massachusetts

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 29, 2025. Always confirm current availability with the study team.

View original record ↗